Global PVA Embolization Particles Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global PVA Embolization Particles Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
PVA Embolization Particles report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PVA Embolization Particles market is projected to reach US$ 1186.9 million in 2034, increasing from US$ 831 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Uterine Fibroid Embolization and Prostatic Artery Embolization are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for PVA Embolization Particles industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PVA Embolization Particles key manufacturers include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. Sirtex Medical, Merit Medical, Cook Medical are top 3 players and held % sales share in total in 2022.
PVA Embolization Particles can be divided into Conventional/Irregular PVA and Compressible and Spherical PVA, etc. Conventional/Irregular PVA is the mainstream product in the market, accounting for % sales share globally in 2022.
PVA Embolization Particles is widely used in various fields, such as Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, etc. Uterine Fibroid Embolization provides greatest supports to the PVA Embolization Particles industry development. In 2022, global % sales of PVA Embolization Particles went into Uterine Fibroid Embolization filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PVA Embolization Particles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Segment by Type
Conventional/Irregular PVA
Compressible and Spherical PVA
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the PVA Embolization Particles market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PVA Embolization Particles, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PVA Embolization Particles industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PVA Embolization Particles in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PVA Embolization Particles introduction, etc. PVA Embolization Particles Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PVA Embolization Particles market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
PVA Embolization Particles report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PVA Embolization Particles market is projected to reach US$ 1186.9 million in 2034, increasing from US$ 831 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Uterine Fibroid Embolization and Prostatic Artery Embolization are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for PVA Embolization Particles industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PVA Embolization Particles key manufacturers include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. Sirtex Medical, Merit Medical, Cook Medical are top 3 players and held % sales share in total in 2022.
PVA Embolization Particles can be divided into Conventional/Irregular PVA and Compressible and Spherical PVA, etc. Conventional/Irregular PVA is the mainstream product in the market, accounting for % sales share globally in 2022.
PVA Embolization Particles is widely used in various fields, such as Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, etc. Uterine Fibroid Embolization provides greatest supports to the PVA Embolization Particles industry development. In 2022, global % sales of PVA Embolization Particles went into Uterine Fibroid Embolization filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PVA Embolization Particles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Segment by Type
Conventional/Irregular PVA
Compressible and Spherical PVA
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the PVA Embolization Particles market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PVA Embolization Particles, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PVA Embolization Particles industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PVA Embolization Particles in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PVA Embolization Particles introduction, etc. PVA Embolization Particles Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PVA Embolization Particles market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices